To this end, we examined the magnitude of influenza transgene-specific T cells immediately prior to entry into the ABSL3 for influenza challenge, which revealed that MCM surviving HPAI challenge mounted significantly higher influenza-specific CD4 + T cell responses in peripheral blood compared to MCM that succumbed (Fig. 3C). This evidence concerns the gene CD4 and influenza.